On January 21st, 2025, he took office, but we’re yet to find out if he’s the great threat to cannabis rescheduling that we think he is. Having Maltz in the DEA office could quite literally be a cannabis prohibitionist’s dream: he has all the right ingredients in place to keep cannabis illegal and stop it from progressing. Rescheduling? Don’t even think about it.
Remember that uncomfortable moment when your parents caught you smoking weed? That dreaded "Talk" that followed - where you sat squirming in your chair while they cycled through concern, disappointment, and those well-worn warnings about the dangers of marijuana. Even though you knew they meant well, it felt like an eternity of awkward silence punctuated by cautionary tales and stern looks.
More recently, in January 2025, a press release was published detailing Vectura Fertin Pharma’s (VFP), a subsidiary of Philip Morris International, joint venture with a Canadian biotech firm focusing on cannabinoid-based drugs – Avicanna. According to the press release, the joint venture seeks to promote cannabis accessibility and research. Avicanna already has a stronghold in the wellness sector. However, the press release hardly makes any other mention about the involvement of Philip Morris International, but it’s clear that Big Tobacco has long had their eye in the cannabis industry.
Advocacy groups are closely monitoring legislative developments and public sentiment, identifying specific states that are likely to make significant strides toward legalization. This article explores the states most likely to legalize marijuana in 2025, examining the political climate, public opinion, and advocacy efforts that may influence these changes.
The researchers then analyzed the mood and emotional regulation capabilities of the participants during times of sobriety as well as when they were stoned from weed. Surprisingly, they found that the subjects’ performance didn’t differ when made to undergo several tasks after smoking weed.
The cannabis industry presents an array of high-paying job opportunities across various sectors—from finance and operations management to marketing and compliance. As legalization continues to spread globally, skilled professionals will be essential for navigating this rapidly evolving landscape.
Recent studies have indicated a notable decrease in prescriptions for anti-anxiety medications, especially benzodiazepines, in states where marijuana has been legalized. This phenomenon raises important questions about the implications for pharmaceutical companies that have long dominated the market for anxiety treatments.
If there's one thing I've learned from years of covering cannabis politics, it's that weed polls better than politicians – and boy, do they know it. It might sound like I'm hitting the bong too hard, but the numbers don't lie. Election after election, cannabis legalization consistently polls higher than any candidate running for office. With pseudo-legalization spreading across the country like wildfire, there are more cannabis supporters than ever before, making us quite the tempting voting bloc.
As we wrap up our deep dive into cannabis and exercise, I can't help but see a massive opportunity on the horizon. With fitness becoming an increasingly central focus in American culture and cannabis users proving to be more active than previously thought, we're looking at the perfect storm for a new kind of wellness revolution.
As you might imagine, telling Americans they can't have their guns AND their ganja isn't exactly going over well. It's a uniquely American saga that pits state rights against federal law, personal freedom against bureaucratic overreach, and common sense against, well... whatever you'd call this situation.
